Opus Genetics (IRD) CFO Gagnon received 200,000 shares
Insider transactions reported
Robert E. Gagnon (Chief Financial Officer at Opus Genetics Inc., IRD) reported that they received 200,000 shares between Sep 2, 2025 and Sep 10, 2025. After these transactions the filing shows 200,000 shares held directly.
- Reporting person
- Gagnon Robert E.
- Role
- Chief Financial Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Sep 10, 2025 | Grant or award (A) | Common Stock1 | +200,000 | - | - | 200,000 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Sep 2, 2025 | Grant or award (A) | Employee Stock Option (right to buy)On 250,000 Common Stock2 | +250,000 | - | - | 250,000 direct |
Holdings before and after
- Common Stock: 0 to 200,000 direct
- Employee Stock Option (right to buy): 0 to 250,000 direct
Footnotes from the filing
- 1. Represents a grant of restricted stock units which vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service.
- 2. The option will vest with respect to 25% on September 2, 2026, with the remaining shares vesting in equal monthly installments on the last day of each full month over the next thirty-six (36) months, subject to the Reporting Person's continuing service.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Gagnon report in this IRD Form 4?
Robert E. Gagnon (Chief Financial Officer at Opus Genetics Inc., IRD) reported that they received 200,000 shares between Sep 2, 2025 and Sep 10, 2025. After these transactions the filing shows 200,000 shares held directly.
How many IRD shares does Gagnon hold after this filing?
The filing shows 200,000 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for IRD
Earlier insider filings at IRD
- Aug 27, 2025Director Gallagher Cam was granted 869,565 shares, increasing direct ownership by 92% to 1,810,430 units (SEC Form 4)
- Aug 27, 2025Director Ainsworth Sean was granted 86,956 shares, increasing direct ownership by 52% to 254,818 units (SEC Form 4)
- May 6, 2025Director Foundation Fighting Blindness Retinal Degeneration Fund converted options into 6,927,419 shares (SEC Form 4)
- May 2, 2025Director Rodgers Richard J was granted 79,504 shares, increasing direct ownership by 33% to 318,655 units (SEC Form 4)
- May 2, 2025Director Manuso James S J was granted 79,504 shares, increasing direct ownership by 44% to 261,763 units (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow IRD and get a push notification the moment its next story breaks.